Advances of virus-like particles as mRNA delivery vectors.
- Author:
Xinyu LIN
1
;
Shuling REN
1
;
Tingdong LI
1
;
Shengxiang GE
1
Author Information
- Publication Type:English Abstract
- Keywords: delivery vectors; mRNA; mRNA drugs; virus-like particles
- MeSH: RNA, Messenger/administration & dosage*; Humans; Nanoparticles/chemistry*; Genetic Vectors; Lipids/chemistry*; Drug Delivery Systems/methods*; Virion; Animals; Gene Transfer Techniques; Liposomes
- From: Chinese Journal of Biotechnology 2025;41(4):1268-1279
- CountryChina
- Language:Chinese
- Abstract: With the continuous development of messenger RNA (mRNA) technology, mRNA-based drugs have shown broad application prospects in recent years. Since mRNA is easy to be degraded and difficult to enter cells directly, the mRNA delivery vectors have always been one of the focuses in the development of mRNA-based drugs. Although lipid nanoparticles (LNPs) have been widely used for the delivery of mRNA, they tend to accumulate in the liver, and repeated administration can easily induce inflammatory response which leads to tissue damage. Compared with LNPs, virus-like particles (VLPs) have the advantages of high biocompatibility and safety, being expected to offer new solutions for mRNA delivery. Based on the practical application requirements, this review summarized the research progress in VLPs according to the mRNA delivery steps: particle assembly, delivery into cells, and intracellular release. We hope to provide a basis and design ideas for the development of new VLPs as delivery vectors, promote the application of VLPs in mRNA delivery, and provide new possibilities for the research and application of mRNA-based therapeutics.
